Skip to main content

Animations

MJFF Publications

5901 - 5925 of 8801 Results
Title
Year
  • Year
  • 2020
  • 2019
  • 2016
  • 2022
  • 2020
  • 2018
  • 2017
  • 2017
  • 2024
  • 2025
  • 2015
  • 2022
  • 2019
  • 2022
  • 2024
  • 2020
  • 2018
  • 2018
  • 2019
  • 2018
  • 2017
  • 2025
  • 2020
  • 2017
  • 2017
  • Summary Details
    RESTRICTED
    Title: Characterization of a Parkinson’s disease rat model using an upgraded paraquat exposure paradigm
    Journal Name: European Journal of Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1111/ejn.14683
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Conversion of Quinazoline Modulators from Inhibitors to Activators of β-Glucocerebrosidase
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jmedchem.8b01294
    Citation Count: 23
  • Summary Details
    RESTRICTED
    Title: Objective characterization of daily living transitions in patients with Parkinson’s disease using a single body-fixed sensor
    Journal Name: Journal of Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s00415-016-8164-6
    Citation Count: 46
  • Summary Details
    OPEN
    Title: Cortical and Subthalamic Nucleus Spectral Changes During Limb Movements in Parkinson's Disease Patients with and Without Dystonia
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29057
    Citation Count: 9
  • Summary Details
    OPEN
    Title: LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficits
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.aav0820
    Citation Count: 114
  • Summary Details
    OPEN
    Title: Multi-objective particle swarm optimization for postoperative deep brain stimulation targeting of subthalamic nucleus pathways
    Journal Name: Journal of Neural Engineering
    Publisher: IOP Publishing
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1088/1741-2552/aae12f
    Citation Count: 37
  • Summary Details
    OPEN
    Title: Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signaling
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-017-0153-4
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Orthostatic hypotension in Parkinson disease: Impact on health care utilization
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.11.344
    Citation Count: 40
  • Summary Details
    OPEN
    Title: RAB12-LRRK2 complex suppresses primary ciliogenesis and regulates centrosome homeostasis in astrocytes
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41467-024-52723-6
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Healthcare access and utilization of deep brain stimulation and supplementary care in black and white patients with Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.108057
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Oligomeric α‐synuclein and β‐amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases
    Journal Name: European Journal of Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/ejn.13056
    Citation Count: 68
  • Summary Details
    OPEN
    Title: Cortico-Subthalamic Field Potentials Support Classification of the Natural Gait Cycle in Parkinson’s Disease and Reveal Individualized Spectral Signatures
    Journal Name: eneuro
    Publisher: Society for Neuroscience
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1523/eneuro.0325-22.2022
    Citation Count: 16
  • Summary Details
    RESTRICTED
    Title: What’s the target: understanding two decades of in silico microRNA-target prediction
    Journal Name: Briefings in Bioinformatics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1093/bib/bbz111
    Citation Count: 51
  • Summary Details
    OPEN
    Title: Sex Differences in Brain and Cognition in de novo Parkinson's Disease
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2021.791532
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Cryogel microcarriers loaded with glial cell line-derived neurotrophic factor enhance the engraftment of primary dopaminergic neurons in a rat model of Parkinson’s disease
    Journal Name: Journal of Neural Engineering
    Publisher: IOP Publishing
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1088/1741-2552/ad7761
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Structure–Functional–Selectivity Relationship Studies of Novel Apomorphine Analogs to Develop D1R/D2R Biased Ligands
    Journal Name: ACS Medicinal Chemistry Letters
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acsmedchemlett.9b00575
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awy072
    Citation Count: 191
  • Summary Details
    OPEN
    Title: Parkinson-Associated SNCA Enhancer Variants Revealed by Open Chromatin in Mouse Dopamine Neurons
    Journal Name: The American Journal of Human Genetics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.ajhg.2018.10.018
    Citation Count: 39
  • Summary Details
    RESTRICTED
    Title: Dystonia as complication of thalamic neurosurgery
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.08.008
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Atrophy in the Thalamus But Not Cerebellum Is Specific for C9orf72 FTD and ALS Patients – An Atlas-Based Volumetric MRI Study
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2018.00045
    Citation Count: 47
  • Summary Details
    RESTRICTED
    Title: The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2017.01.012
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Personalised regional modelling predicts tau progression in the human brain
    Journal Name: PLOS Biology
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pbio.3003241
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Innovative Recruitment Strategies to Increase Diversity of Participation in Parkinson’s Disease Research: The Fox Insight Cohort Experience
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3233/jpd-191901
    Citation Count: 48
  • Summary Details
    OPEN
    Title: Fine-Tuning ER Stress Signal Transducers to Treat Amyotrophic Lateral Sclerosis
    Journal Name: Frontiers in Molecular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnmol.2017.00216
    Citation Count: 24
  • Summary Details
    RESTRICTED
    Title: More than constipation – bowel symptoms in Parkinson's disease and their connection to gut microbiota
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1111/ene.13398
    Citation Count: 141
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.